These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6065687)

  • 1. Defective transport of aminopterin in relation to development of resistance in Yoshida sarcoma cells.
    Braganca BM; Divekar AY; Vaidya NR
    Biochim Biophys Acta; 1967; 135(5):937-46. PubMed ID: 6065687
    [No Abstract]   [Full Text] [Related]  

  • 2. Active transport of aminopterin in Yoshida sarcoma cells.
    Divekar AY; Vaidya NR; Braganca BM
    Biochim Biophys Acta; 1967; 135(5):927-36. PubMed ID: 4229073
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on inhibiting effect of aminopterin and other folic acid antagonist, and folic acid upon the Yoshida sarcoma.
    ASANO T
    Tohoku J Exp Med; 1953 Feb; 57(2-3):221-5. PubMed ID: 13090205
    [No Abstract]   [Full Text] [Related]  

  • 4. Biochemical and pharmacologic properties of a new folate analog, 10-deaza-aminopterin, in mice.
    Sirotnak FM; DeGraw JI; Chello PL; Moccio DM; Dorick DM
    Cancer Treat Rep; 1982 Feb; 66(2):351-8. PubMed ID: 7055818
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative studies on the transport of aminopterin, methotrexate, and methasquin by the L1210 leukemia cell.
    Sirotnak FM; Donsbach RC
    Cancer Res; 1972 Oct; 32(10):2120-6. PubMed ID: 4404161
    [No Abstract]   [Full Text] [Related]  

  • 6. Number of binding sites and possible mechanisms of action.
    Condit PT
    Ann N Y Acad Sci; 1971 Nov; 186():363-4. PubMed ID: 4943807
    [No Abstract]   [Full Text] [Related]  

  • 7. Sites of action of amethopterin: intrinsic and acquired drug resistance.
    Harrap KR; Hill BT; Furness ME; Hart LI
    Ann N Y Acad Sci; 1971 Nov; 186():312-24. PubMed ID: 5289423
    [No Abstract]   [Full Text] [Related]  

  • 8. Competitive dihydrofolate reductase binding assay of triazinate (NSC-139105), methasquin (NSC-122870), and aminopterin (NSC739).
    Myers CE; Eliot HM; Chabner BA
    Cancer Treat Rep; 1976 May; 60(5):615-6. PubMed ID: 1033031
    [No Abstract]   [Full Text] [Related]  

  • 9. Mechanisms of sensitivity and natural resistance to antifolates in a methylcholanthrene-induced rat sarcoma.
    Li WW; Lin JT; Schweitzer BI; Bertino JR
    Mol Pharmacol; 1991 Nov; 40(5):854-8. PubMed ID: 1719370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Similar characteristics of folate analogue transport in vitro in contrast to varying dihydrofolate reductase levels in epithelial cells at different stages of maturation in mouse small intestine.
    Sirotnak FM; Moccio DM; Yang CH
    Cancer Res; 1984 Nov; 44(11):5204-11. PubMed ID: 6488181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dihydrofolate reductases from the wild type and aminopterin-resistant mutants of Diplococcus pneumoniae.
    Trombe MC; Sicard AM
    J Bacteriol; 1975 Mar; 121(3):766-70. PubMed ID: 234945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence and properties of dihydrofolate reductases within the genus Trypanosoma.
    Gutteridge WE; Jaffe JJ; McCormack JJ
    Br J Pharmacol; 1968 Sep; 34(1):191P-192P. PubMed ID: 4300138
    [No Abstract]   [Full Text] [Related]  

  • 13. Histochemical pattern of tetrahydrofolate dehydrogenase in hemopoietic cells following folate antagonist treatment in vivo.
    Nano R; Gerzeli G; Gervaso MV; De Piceis Polver P; Arisi C
    Cell Mol Biol Incl Cyto Enzymol; 1979; 24(3):191-7. PubMed ID: 498204
    [No Abstract]   [Full Text] [Related]  

  • 14. Two different effects of mutation on the binding of folate antagonists by a microbial dihydrofolate reductase.
    Sirotnak FM
    Biochim Biophys Acta; 1973 Mar; 302(1):13-23. PubMed ID: 4144236
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytotoxicity, uptake, polyglutamate formation, and antileukemic effects of 8-deaza analogues of methotrexate and aminopterin in mice.
    Kuehl M; Brixner DI; Broom AD; Avery TL; Blakley RL
    Cancer Res; 1988 Mar; 48(6):1481-8. PubMed ID: 2449950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer research: from folate antagonism to molecular targets.
    Bertino JR
    Best Pract Res Clin Haematol; 2009 Dec; 22(4):577-82. PubMed ID: 19959110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biochemical aspects of folate transport].
    Totskiĭ VN; Bondarchuk NG
    Usp Sovrem Biol; 1979; 88(3):353-66. PubMed ID: 395787
    [No Abstract]   [Full Text] [Related]  

  • 18. Cobra-venom protein preferentially cytotoxic to certain cell types including Yoshida sarcoma cells and its effects on lipid constituents of cell surface membrane.
    Braganca BM; Patel TN
    Biochem J; 1972 Jun; 128(1):46P. PubMed ID: 4673573
    [No Abstract]   [Full Text] [Related]  

  • 19. Mechanism of resistance of Yoshida sarcoma to nitrogen mustard. 3. Mechanism of suppressed transport of nitrogen mustard.
    Inaba M
    Int J Cancer; 1973 Jan; 11(1):231-6. PubMed ID: 4790837
    [No Abstract]   [Full Text] [Related]  

  • 20. DNA synthesis as a therapeutic target: the first 65 years.
    Mathews CK
    FASEB J; 2012 Jun; 26(6):2231-7. PubMed ID: 22653564
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.